Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci Sells 13,770 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 13,770 shares of the firm’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $60.00, for a total value of $826,200.00. Following the sale, the chief accounting officer now owns 57,237 shares in the company, valued at $3,434,220. The trade was a 19.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Tempus AI Stock Up 0.3 %

Tempus AI stock opened at $57.39 on Friday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $79.49. The firm has a 50-day moving average of $44.18 and a 200-day moving average of $48.18.

Analysts Set New Price Targets

A number of brokerages recently weighed in on TEM. Guggenheim began coverage on Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective on the stock. Loop Capital decreased their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Bank of America upped their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the company from $45.00 to $65.00 in a report on Monday, November 11th. Finally, Piper Sandler reissued a “neutral” rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, Tempus AI has an average rating of “Moderate Buy” and a consensus target price of $56.36.

Institutional Investors Weigh In On Tempus AI

Institutional investors and hedge funds have recently bought and sold shares of the business. Squarepoint Ops LLC purchased a new position in shares of Tempus AI during the second quarter valued at approximately $633,000. Millennium Management LLC bought a new stake in Tempus AI in the second quarter valued at $8,067,000. The Manufacturers Life Insurance Company purchased a new position in Tempus AI during the 2nd quarter valued at $946,000. Teachers Retirement System of The State of Kentucky bought a new position in Tempus AI in the 2nd quarter worth $4,165,000. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Tempus AI in the 2nd quarter worth about $5,250,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.